ID: ALA24868

Max Phase: Preclinical

Molecular Formula: C8H10ClN5O2

Molecular Weight: 243.65

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1nc(Cl)c2ncn(COCCO)c2n1

Standard InChI:  InChI=1S/C8H10ClN5O2/c9-6-5-7(13-8(10)12-6)14(3-11-5)4-16-2-1-15/h3,15H,1-2,4H2,(H2,10,12,13)

Standard InChI Key:  BSFGGUCAZGXDGK-UHFFFAOYSA-N

Associated Targets(non-human)

Adenosine deaminase 739 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Human alphaherpesvirus 1 11089 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Human alphaherpesvirus 2 4932 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Vaccinia virus 4609 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Vesicular stomatitis virus 4460 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

L1210 27553 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 243.65Molecular Weight (Monoisotopic): 243.0523AlogP: 0.03#Rotatable Bonds: 4
Polar Surface Area: 99.08Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 2.28CX LogP: -0.03CX LogD: -0.03
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.58Np Likeness Score: -0.66

References

1. Kim D, Kim H, Chae Y.  (1994)  Design and synthesis of 6-fluoropurine acyclonucleosides : potential prodrugs of acyclovir and ganciclovir,  (11): [10.1016/S0960-894X(01)80350-4]
2. Robins MJ, Hatfield PW, Balzarini J, De Clercq E..  (1984)  Nucleic acid related compounds. 47. Synthesis and biological activities of pyrimidine and purine "acyclic" nucleoside analogues.,  27  (11): [PMID:6092636] [10.1021/jm00377a018]
3. Helguera AM, Rodríguez-Borges JE, García-Mera X, Fernández F, Cordeiro MN..  (2007)  Probing the anticancer activity of nucleoside analogues: a QSAR model approach using an internally consistent training set.,  50  (7): [PMID:17341060] [10.1021/jm061445m]
4. Johnson BM, Shu YZ, Zhuo X, Meanwell NA..  (2020)  Metabolic and Pharmaceutical Aspects of Fluorinated Compounds.,  63  (12): [PMID:32182061] [10.1021/acs.jmedchem.9b01877]

Source